Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Point Biopharma, A Wholly Owned Subsidiary Of Eli Lilly And Company

Clinical trials sponsored by Point Biopharma, A Wholly Owned Subsidiary Of Eli Lilly And Company, explained in plain language.

Not yet finished but already full! 1

Radioactive 'Tumor-Seeking' therapy battles advanced prostate cancer in major trial

Disease control Ongoing

This study is testing whether a new radioactive drug that targets prostate cancer cells (called [Lu-177]-PNT2002) works better than standard hormone drugs for men with advanced prostate cancer that has spread and is no longer controlled by standard treatments. About 455 men whose…

Phase: PHASE3 • Sponsor: POINT Biopharma, a wholly owned subsidiary of Eli Lilly and Company • Aim: Disease control

Last updated Mar 30, 2026 14:29 UTC